Developer docs
API playgroundTry for free, no card

Search company profiles

Tatva Chintan

Full company profile

uuid000zg26

Namestring
Tatva Chintan
Legal namestring
Tatva Chintan Pharma Chem Limited
Company typeenum
Public
Founded yearint
1996
Descriptiontext

Tatva Chintan Pharma Chem Limited, founded in 1996 in Ankleshwar, Gujarat and headquartered in Vadodara, is a publicly listed Indian specialty chemicals manufacturer (NSE: TATVA, BSE: 543321; listed 2021) operating across five product categories: Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA) for zeolites, Electrolyte Salts and Solutions (ESS) for supercapacitor batteries, Pharmaceutical & Agrochemical Intermediates and Other Specialty Chemicals (PASC) including glymes, and Brominated Flame Retardants (BFR). The company is the world's second-largest producer of SDAs for zeolites, India's largest producer of Electrolyte Salts for supercapacitors, and India's largest producer of glymes, with a portfolio of 150+ specialty chemicals. Customers span pharmaceutical, agrochemical, automotive (catalytic converters, EV battery components), energy storage and renewable energy, industrial and consumer products (paints, coatings, detergents, textiles), and personal care and disinfectant manufacturers.

The company operates two manufacturing facilities in Gujarat — the original Ankleshwar plant (since 1996) and the Dahej SEZ plant (since 2017) — with a cumulative licensed capacity of 48,000 Tonnes Per Annum. Its R&D center in Vadodara is recognized by India's Department of Scientific and Industrial Research (DSIR) and houses continuous flow reactors, high-pressure autoclaves (10–300°C, up to 100 bar), and an in-house Analytical & Development Laboratory with PPB-level impurity detection. The business is supported by wholly-owned foreign subsidiaries — Tatva Chintan USA Inc. (established 2015, with warehousing in Savannah, Georgia) and Tatva Chintan Europe B.V. (established 2019, with warehousing in Amsterdam) — that handle direct sales and distribution across North/South America and Europe.

Tatva Chintan operates a B2B enterprise field sales model with dedicated domestic and global sales departments, quote-based pricing, and direct customer engagement through [email protected] and [email protected]. Manufacturing sites are strategically located near the Nhava Sheva and Hazira shipping ports to support export logistics. The company holds ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and ISO 22716:2007 certifications, is REACH-compliant, RSPO-certified, and has received EcoVadis and Together for Sustainability ratings. For FY2025-26, Tatva Chintan reported ₹496.30 crore in revenue (35.45% YoY growth) and ₹39.08 crore in net profit, with Q4 FY25-26 delivering its highest-ever quarterly net sales of ₹134.14 crore at a 20.97% operating margin.

Short descriptiontext

Tatva Chintan Pharma Chem Limited is a publicly listed Indian specialty chemicals manufacturer founded in 1996, producing 150+ products across phase transfer catalysts, structure directing agents, electrolyte salts, pharmaceutical and agrochemical intermediates, and brominated flame retardants for pharmaceutical, agrochemical, automotive, and energy storage customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersVadodara, India
HQ citystring
Vadodara
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty chemicals manufacturing, phase transfer catalysts, structure directing agents, electrolyte salts, pharmaceutical intermediates
Industry3 codes
1Precious Metals & Catalyst Materials (PGM Catalysts)
CodeIMAEAIANPrimaryYes
2Formulation R&D, Scale-Up & Tech Transfer Services
CodeAFABAIAJPrimaryNo
3Bulk Industrial Solvents
CodeIMAEAAAEPrimaryNo
NAICS code3 codes
  • Chemical Manufacturing325
  • Other Chemical Product and Preparation Manufacturing3259
  • All Other Basic Organic Chemical Manufacturing325199
SIC code2 codes
  • Industrial Organic Chemicals2860
  • Chemicals & Allied Products2800
Product category
Specialty Chemicals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Specialty Chemicals Manufacturing
TypeOne Time License
Description

Manufacture and sale of specialty chemicals including Phase Transfer Catalysts, Structure Directing Agents, Electrolyte Salts, Pharmaceutical & Agrochemical Intermediates, and Brominated Flame Retardants to pharmaceutical, agrochemical, automotive, and other industrial customers globally.

tatvachintan.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Tatva Chintan Pharma Chem Limited manufactures and sells a niche portfolio of over 150 specialty chemicals across five core categories: Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA) for zeolites, Electrolyte Salts and Solutions (ESS) for supercapacitors, Pharmaceutical & Agrochemical Intermediates and Other Specialty Chemicals (PASC), and Brominated Flame Retardants (BFR). The company serves pharmaceutical, agrochemical, automotive, energy storage, and industrial customers globally through two manufacturing facilities in Gujarat, India with 48,000 MTPA cumulative licensed capacity, a DSIR-recognized R&D center in Vadodara, and wholly-owned sales subsidiaries in the USA and the Netherlands.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Revenue grew 35.45% year-over-year to ₹496.30 crore in FY2025-26
+2 more records
Product overview1 text field

Tatva Chintan Pharma Chem Limited is a specialty chemicals manufacturer offering a niche portfolio of products across five core categories: Phase Transfer Catalysts (PTC) for facilitating reactions in pharmaceutical and agrochemical applications, Structure Directing Agents (SDA) for zeolite synthesis making it the world's second-largest manufacturer, Electrolyte Salts and Solutions (ESS) for supercapacitor batteries making it India's largest producer, Pharmaceutical & Agrochemical Intermediates and Other Specialty Chemicals (PASC) including glymes, and Brominated Flame Retardants (BFR). The company operates two manufacturing facilities in Ankleshwar and Dahej, Gujarat with a cumulative licensed capacity of 48,000 Tonnes Per Annum, and maintains R&D facilities in Vadodara.

Product and service5 records
1Phase Transfer Catalysts (PTC)
CategoryPhase Transfer Catalysts
Description

A comprehensive array of phase transfer catalysts used in pharmaceutical APIs, agrochemicals, and personal care applications for facilitating reactions between immiscible phases. Tatva Chintan is a leading producer of PTCs in India.

2Structure Directing Agents (SDA)
CategoryStructure Directing Agents
Description

Agents used in zeolite synthesis for automotive catalytic converters, petrochemical cracking, continuous flow chemistry, and oxygen concentrators. Tatva Chintan is the world's second-largest manufacturer of SDAs for zeolites and the sole commercial supplier in India.

3Electrolyte Salts and Solutions (ESS)
CategoryElectrolyte Salts
Description

Electrolyte salts for supercapacitor batteries used in electrical and hybrid vehicles, transport infrastructure, renewable energy systems, and consumer electronics. Tatva Chintan is India's largest producer of electrolyte salts for supercapacitor batteries.

4Pharmaceutical & Agrochemical Intermediates and Other Specialty Chemicals (PASC)
CategoryPharmaceutical & Agrochemical Intermediates
Description

Specialty chemical intermediates including monoglyme, diglyme, tetraglyme, and various ammonium compounds used in pharmaceutical synthesis, agrochemical production, paints, coatings, detergents, and textiles. Tatva Chintan is the largest producer of glymes in India.

5Brominated Flame Retardants (BFR)
CategoryFlame Retardants
Description

Flame retardant products including Tetra Bromo Bisphenol A (TBPA), Tri Bromo Phenol (TBP), and Deca Bromo Diphenyl Ethane (DBE) used for fire safety applications in industrial and consumer products.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move14 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

German specialty chemicals company with strong positions in catalysts, additives, and intermediates for pharma/automotive customers. Comparable to Tatva's specialty intermediates and electrolyte/catalyst product lines as a much larger global incumbent.

TypeBroad incumbent
Description

German specialty chemicals giant with a major catalysts and additives business serving automotive, pharma, and industrial customers. Comparable to Tatva's catalyst (PTC/SDA) and intermediates portfolio, though Lanxess is far larger and operates globally with broader product breadth.

TypeDirect peer
Description

Indian specialty chemicals company with intermediates, fluorochemicals, and packaging films. Comparable on Indian specialty chemicals manufacturing scale, R&D-driven product portfolio, global customer base, and publicly listed mid/large-cap profile.

TypeDirect peer
Description

Indian specialty chemicals manufacturer producing intermediates for pharmaceuticals, agrochemicals, and performance chemicals. Closely comparable to Tatva on geography (India), business model (B2B specialty intermediates), end-market mix (pharma/agro), and listed mid-cap profile.

TypeBroad incumbent
Description

US diversified industrial with specialty chemicals, catalysts, and battery materials relevant to Tatva's PTC, SDA, and electrolyte salt product lines. Comparable as a large global incumbent serving similar automotive and energy storage end markets.

TypeDirect peer
Description

Indian diversified specialty chemicals manufacturer across multiple product categories. Comparable on Indian specialty chemicals manufacturing heritage, multi-category portfolio approach, and B2B customer mix spanning pharma, agro, and industrial segments.

TypeDirect peer
Description

US-based specialty chemicals producer of quaternary ammonium compounds, phosphonium salts, and catalytic intermediates. Closely comparable to Tatva's Phase Transfer Catalyst (quaternary ammonium/phosphonium salts) and specialty intermediates portfolio, with similar niche B2B positioning.

TypeDirect peer
Description

Indian specialty/fluorine chemicals manufacturer serving pharma, agro, and industrial customers. Comparable to Tatva on Indian specialty chemicals manufacturing, intermediates-to-pharma pipeline, and listed status with similar end-market exposure.

TypeBroad incumbent
Description

Belgian specialty chemicals producer with materials, advanced formulations, and catalyst adjacencies. Comparable to Tatva's specialty chemicals positioning in automotive and industrial end markets, with substantially broader scale and global footprint.

TypeBroad incumbent
Description

World's largest chemical company with extensive specialty intermediates, catalysts, and additives businesses serving pharma, agro, and automotive. Relevant comparable for Tatva's portfolio breadth and end-market overlap, though at vastly larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tatva Chintan

Specialty Chemicalstatvachintan.com

Tatva Chintan Pharma Chem Limited is a publicly listed Indian specialty chemicals manufacturer founded in 1996, producing 150+ products across phase transfer catalysts, structure directing agents, electrolyte salts, pharmaceutical and agrochemical intermediates, and brominated flame retardants for pharmaceutical, agrochemical, automotive, and energy storage customers globally.

What Tatva Chintan does

Tatva Chintan Pharma Chem Limited, founded in 1996 in Ankleshwar, Gujarat and headquartered in Vadodara, is a publicly listed Indian specialty chemicals manufacturer (NSE: TATVA, BSE: 543321; listed 2021) operating across five product categories: Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA) for zeolites, Electrolyte Salts and Solutions (ESS) for supercapacitor batteries, Pharmaceutical & Agrochemical Intermediates and Other Specialty Chemicals (PASC) including glymes, and Brominated Flame Retardants (BFR). The company is the world's second-largest producer of SDAs for zeolites, India's largest producer of Electrolyte Salts for supercapacitors, and India's largest producer of glymes, with a portfolio of 150+ specialty chemicals. Customers span pharmaceutical, agrochemical, automotive (catalytic converters, EV battery components), energy storage and renewable energy, industrial and consumer products (paints, coatings, detergents, textiles), and personal care and disinfectant manufacturers.

The company operates two manufacturing facilities in Gujarat — the original Ankleshwar plant (since 1996) and the Dahej SEZ plant (since 2017) — with a cumulative licensed capacity of 48,000 Tonnes Per Annum. Its R&D center in Vadodara is recognized by India's Department of Scientific and Industrial Research (DSIR) and houses continuous flow reactors, high-pressure autoclaves (10–300°C, up to 100 bar), and an in-house Analytical & Development Laboratory with PPB-level impurity detection. The business is supported by wholly-owned foreign subsidiaries — Tatva Chintan USA Inc. (established 2015, with warehousing in Savannah, Georgia) and Tatva Chintan Europe B.V. (established 2019, with warehousing in Amsterdam) — that handle direct sales and distribution across North/South America and Europe.

Tatva Chintan operates a B2B enterprise field sales model with dedicated domestic and global sales departments, quote-based pricing, and direct customer engagement through [email protected] and [email protected]. Manufacturing sites are strategically located near the Nhava Sheva and Hazira shipping ports to support export logistics. The company holds ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and ISO 22716:2007 certifications, is REACH-compliant, RSPO-certified, and has received EcoVadis and Together for Sustainability ratings. For FY2025-26, Tatva Chintan reported ₹496.30 crore in revenue (35.45% YoY growth) and ₹39.08 crore in net profit, with Q4 FY25-26 delivering its highest-ever quarterly net sales of ₹134.14 crore at a 20.97% operating margin.

Tatva Chintan firmographics

Firmographics
Name
Tatva Chintan
Legal name
Tatva Chintan Pharma Chem Limited
Website
https://tatvachintan.com
Company type
Public
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Short description
Tatva Chintan Pharma Chem Limited is a publicly listed Indian specialty chemicals manufacturer founded in 1996, producing 150+ products across phase transfer catalysts, structure directing agents, electrolyte salts, pharmaceutical and agrochemical intermediates, and brominated flame retardants for pharmaceutical, agrochemical, automotive, and energy storage customers globally.
Ownership category
akta.pro rank

Tatva Chintan industry classification

Industry
Product category
Specialty Chemicals
NAICS
Chemical Manufacturing (325), Other Chemical Product and Preparation Manufacturing (3259), All Other Basic Organic Chemical Manufacturing (325199)
SIC
Industrial Organic Chemicals (2860), Chemicals & Allied Products (2800)
akta.pro primary industry
Precious Metals & Catalyst Materials (PGM Catalysts) (IMAEAIAN)
akta.pro secondary industries
Formulation R&D, Scale-Up & Tech Transfer Services (AFABAIAJ), Bulk Industrial Solvents (IMAEAAAE)

Keywords

  • Specialty chemicals manufacturing
  • Phase transfer catalysts
  • Structure directing agents
  • Electrolyte salts
  • Pharmaceutical intermediates

Where Tatva Chintan is headquartered

Location

Headquarters

HQ city
Vadodara
HQ country
India
HQ region
Asia

Offices5 records

Markets served

Tatva Chintan business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Specialty Chemicals Manufacturing: Manufacture and sale of specialty chemicals including Phase Transfer Catalysts, Structure Directing Agents, Electrolyte Salts, Pharmaceutical & Agrochemical Intermediates, and Brominated Flame Retardants to pharmaceutical, agrochemical, automotive, and other industrial customers globally.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Tatva Chintan product offering

Product offering

Core offering

Tatva Chintan Pharma Chem Limited manufactures and sells a niche portfolio of over 150 specialty chemicals across five core categories: Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA) for zeolites, Electrolyte Salts and Solutions (ESS) for supercapacitors, Pharmaceutical & Agrochemical Intermediates and Other Specialty Chemicals (PASC), and Brominated Flame Retardants (BFR). The company serves pharmaceutical, agrochemical, automotive, energy storage, and industrial customers globally through two manufacturing facilities in Gujarat, India with 48,000 MTPA cumulative licensed capacity, a DSIR-recognized R&D center in Vadodara, and wholly-owned sales subsidiaries in the USA and the Netherlands.

Product overview

Tatva Chintan Pharma Chem Limited is a specialty chemicals manufacturer offering a niche portfolio of products across five core categories: Phase Transfer Catalysts (PTC) for facilitating reactions in pharmaceutical and agrochemical applications, Structure Directing Agents (SDA) for zeolite synthesis making it the world's second-largest manufacturer, Electrolyte Salts and Solutions (ESS) for supercapacitor batteries making it India's largest producer, Pharmaceutical & Agrochemical Intermediates and Other Specialty Chemicals (PASC) including glymes, and Brominated Flame Retardants (BFR). The company operates two manufacturing facilities in Ankleshwar and Dahej, Gujarat with a cumulative licensed capacity of 48,000 Tonnes Per Annum, and maintains R&D facilities in Vadodara.

Differentiator

Problem solved

Functional benefit

Products and services

  • Phase Transfer Catalysts (PTC) A comprehensive array of phase transfer catalysts used in pharmaceutical APIs, agrochemicals, and personal care applications for facilitating reactions between immiscible phases. Tatva Chintan is a leading producer of PTCs in India.
  • Structure Directing Agents (SDA) Agents used in zeolite synthesis for automotive catalytic converters, petrochemical cracking, continuous flow chemistry, and oxygen concentrators. Tatva Chintan is the world's second-largest manufacturer of SDAs for zeolites and the sole commercial supplier in India.
  • Electrolyte Salts and Solutions (ESS) Electrolyte salts for supercapacitor batteries used in electrical and hybrid vehicles, transport infrastructure, renewable energy systems, and consumer electronics. Tatva Chintan is India's largest producer of electrolyte salts for supercapacitor batteries.
  • Pharmaceutical & Agrochemical Intermediates and Other Specialty Chemicals (PASC) Specialty chemical intermediates including monoglyme, diglyme, tetraglyme, and various ammonium compounds used in pharmaceutical synthesis, agrochemical production, paints, coatings, detergents, and textiles. Tatva Chintan is the largest producer of glymes in India.
  • Brominated Flame Retardants (BFR) Flame retardant products including Tetra Bromo Bisphenol A (TBPA), Tri Bromo Phenol (TBP), and Deca Bromo Diphenyl Ethane (DBE) used for fire safety applications in industrial and consumer products.

Quantifiable outcome

  • Revenue grew 35.45% year-over-year to ₹496.30 crore in FY2025-26
  • +2 more outcomes

Companies that use Tatva Chintan

Customer profile

Segments6 records

Ideal customer profiles5 records

Tatva Chintan technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Tatva Chintan partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves14 records

Expansion highlights6 records

Tatva Chintan competitors and assessment

Company assessment

Broad incumbents

  • Evonik Industries: German specialty chemicals company with strong positions in catalysts, additives, and intermediates for pharma/automotive customers. Comparable to Tatva's specialty intermediates and electrolyte/catalyst product lines as a much larger global incumbent.
  • Lanxess AG: German specialty chemicals giant with a major catalysts and additives business serving automotive, pharma, and industrial customers. Comparable to Tatva's catalyst (PTC/SDA) and intermediates portfolio, though Lanxess is far larger and operates globally with broader product breadth.
  • Honeywell International (Performance Materials): US diversified industrial with specialty chemicals, catalysts, and battery materials relevant to Tatva's PTC, SDA, and electrolyte salt product lines. Comparable as a large global incumbent serving similar automotive and energy storage end markets.
  • Solvay SA: Belgian specialty chemicals producer with materials, advanced formulations, and catalyst adjacencies. Comparable to Tatva's specialty chemicals positioning in automotive and industrial end markets, with substantially broader scale and global footprint.
  • BASF SE: World's largest chemical company with extensive specialty intermediates, catalysts, and additives businesses serving pharma, agro, and automotive. Relevant comparable for Tatva's portfolio breadth and end-market overlap, though at vastly larger scale.

Direct peers

  • SRF Limited: Indian specialty chemicals company with intermediates, fluorochemicals, and packaging films. Comparable on Indian specialty chemicals manufacturing scale, R&D-driven product portfolio, global customer base, and publicly listed mid/large-cap profile.
  • Aarti Industries: Indian specialty chemicals manufacturer producing intermediates for pharmaceuticals, agrochemicals, and performance chemicals. Closely comparable to Tatva on geography (India), business model (B2B specialty intermediates), end-market mix (pharma/agro), and listed mid-cap profile.
  • Atul Limited: Indian diversified specialty chemicals manufacturer across multiple product categories. Comparable on Indian specialty chemicals manufacturing heritage, multi-category portfolio approach, and B2B customer mix spanning pharma, agro, and industrial segments.
  • Vertellus Specialties: US-based specialty chemicals producer of quaternary ammonium compounds, phosphonium salts, and catalytic intermediates. Closely comparable to Tatva's Phase Transfer Catalyst (quaternary ammonium/phosphonium salts) and specialty intermediates portfolio, with similar niche B2B positioning.
  • Navin Fluorine International: Indian specialty/fluorine chemicals manufacturer serving pharma, agro, and industrial customers. Comparable to Tatva on Indian specialty chemicals manufacturing, intermediates-to-pharma pipeline, and listed status with similar end-market exposure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Tatva Chintan social profiles

Digital presence

Tatva Chintan compliance and trust

Trust signal

Compliance9 records

Tatva Chintan financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tatva Chintan leadership team

Management profile

Number of profiles

Profiles8 records

Tatva Chintan subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Tatva Chintan funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tatva Chintan M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tatva Chintan

What does Tatva Chintan do?

Tatva Chintan Pharma Chem Limited manufactures and sells a niche portfolio of over 150 specialty chemicals across five core categories: Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA) for zeolites, Electrolyte Salts and Solutions (ESS) for supercapacitors, Pharmaceutical & Agrochemical Intermediates and Other Specialty Chemicals (PASC), and Brominated Flame Retardants (BFR). The company serves pharmaceutical, agrochemical, automotive, energy storage, and industrial customers globally through two manufacturing facilities in Gujarat, India with 48,000 MTPA cumulative licensed capacity, a DSIR-recognized R&D center in Vadodara, and wholly-owned sales subsidiaries in the USA and the Netherlands.

Is Tatva Chintan a public or private company?

Tatva Chintan is a public company. It is classified as public and is currently operating.

When was Tatva Chintan founded?

Tatva Chintan was founded in 1996. It employs 101 to 250 people.

Where is Tatva Chintan based?

Tatva Chintan is headquartered in Vadodara, India, in the Asia region.

How does Tatva Chintan make money?

One revenue line is on record: specialty Chemicals Manufacturing.

Who are Tatva Chintan's main competitors?

Broad incumbents on record are Evonik Industries, Lanxess AG, Honeywell International (Performance Materials), Solvay SA and BASF SE. Direct peers are SRF Limited, Aarti Industries, Atul Limited, Vertellus Specialties and Navin Fluorine International.

Does Tatva Chintan have an API?

No public API is recorded for Tatva Chintan.

What industry is Tatva Chintan in?

Tatva Chintan's product category is Specialty Chemicals. Its primary akta.pro industry code is IMAEAIAN, Precious Metals & Catalyst Materials (PGM Catalysts), with a secondary code of AFABAIAJ, Formulation R&D, Scale-Up & Tech Transfer Services. Its NAICS code is 325 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXTatva Chintan Pharma Chem files FY26 BRSR; turnover at ₹4,962.96 millionTatva Chintan Pharma Chem Limited filed its FY26 Business Responsibility and Sustainability Report, disclosing a standalone turnover of ₹4,962.96 million and net worth of ₹7,582.29 million. Exports contributed 75% of revenue, while non-renewable energy use rose to 285,897.23 GJ and Scope 1 emissions to 10,637.93 t CO₂ eq. The workforce comprises 363 permanent employees and 734 workers.ScanXTatva Chintan Pharma sets Sept 10 deadline for dividend tax docsTatva Chintan Pharma Chem Limited has set a deadline of September 10, 2026, for shareholders to submit tax documents related to its final dividend, affecting resident and non-resident investors' TDS rates. The company also announced a virtual analyst meet with Mahindra Manulife Investment Management scheduled for August 6, 2026. The article discusses potential impacts on liquidity, trading volume, and investor participation.ScanXTatva Chintan Pharma hosts virtual analyst meet on Aug 6Tatva Chintan Pharma Chem Limited announced a virtual one-to-one analyst meet with ChrysCapital Associates LLP scheduled for August 6, 2026, filed under SEBI Regulation 30. The company stated that no unpublished price-sensitive information will be disclosed during the meeting, ensuring compliance with listing obligations. This is a routine investor relations event as part of the company's ongoing engagement with institutional investors.Business News TodayTatva Chintan Standalone June 2026 Net Sales at Rs 146.70 crore, up 34.37% Y-o-Y- Moneycontrol.comTatva Chintan Pharma Chem reported standalone quarterly financial results for June 2026, with net sales increasing 34.37% year-on-year to Rs 146.70 crore from Rs 109.18 crore in June 2025. Net profit more than doubled, rising 103.51% to Rs 10.45 crore from Rs 5.13 crore, while EBITDA grew 70.68% to Rs 28.06 crore. The company's EPS improved to Rs 4.47 from Rs 2.19 in the prior year period.Simply Wall StTatva Chintan Pharma Chem Limited (NSE:TATVA) Beat Earnings, And Analysts Have Been Reviewing Their ForecastsTatva Chintan Pharma Chem Limited reported quarterly results with revenue of ₹1.7 billion and statutory EPS of ₹6.83, both beating analyst estimates by more than 10%. The company's three analysts maintained their 2027 revenue forecast at ₹6.39 billion and reconfirmed the price target at ₹1,443, indicating execution in line with expectations. Looking ahead, analysts expect per-share earnings to surge 39% to ₹30.50 by 2027, representing 20% annualized growth that significantly outpaces the industry forecast of 12%.ScanXTatva Chintan Q1 net profit rises 54.8% to ₹159.81 millionTatva Chintan Pharma Chem Limited reported a 54.8% year-on-year increase in consolidated net profit to ₹159.81 million for the quarter ended June 30, 2026. Total income from operations rose 43% to ₹1,670.55 million, while earnings per share stood at ₹6.83. The company conducted a groundbreaking ceremony for a new greenfield unit at Dahej, Gujarat, with an investment of approximately ₹200 crore to add 344 kilolitres of reactor capacity.IndianchemicalnewsTatva Chintan Q1 FY27 profit soars 140% to Rs. 15.98 crore as specialty chemical demand reboundsTatva Chintan Pharma Chem Limited reported a 140.3% year-on-year surge in consolidated net profit for Q1 FY27 (quarter ended June 30, 2026), reaching Rs. 15.98 crore compared with Rs. 6.65 crore in Q1 FY26. Revenue from operations climbed 42.9% year-on-year to Rs. 167.06 crore, driven by a recovery across specialty chemicals, structure-directing agents, and green pharmaceutical intermediates. Profit before tax jumped 132% to Rs. 21.11 crore despite a one-time exceptional expense of Rs. 1.32 crore.Business TodayTatva Chintan Pharma shares hit upper circuit; ICICI Securities shares price targetTatva Chintan Pharma Chem reported strong Q1 earnings for the quarter ended June 2026, with net profit surging 140% year-on-year to Rs 16 crore and revenue rising 43% to Rs 167.1 crore. The company's shares rallied 20% to hit a 52-week high of Rs 1714, pushing its market cap to Rs 3971.27 crore. ICICI Securities has assigned a price target of Rs 1955 to the stock, while the management reiterated its FY27 guidance of 25-30% revenue growth and EBITDA margin of 20-22%.Zee BusinessWhy are pharma stocks rising today? Tatva Chintan jumps 20%; Cipla, Torrent Pharma, Mankind gain; should you buy?Pharmaceutical stocks in India outperformed the broader market on Monday, with Tatva Chintan Pharma Chem shares surging 20% to a new 52-week high of Rs 1,714.10 following its June-quarter financial results, while Torrent Pharmaceuticals and Mankind Pharma each rose over 3% and led gains on the Nifty Pharma index. The rally, which sent the Nifty Pharma index up 1.65%, was driven by quarterly earnings, fresh brokerage recommendations, and expectations ahead of upcoming results, as investors reduced exposure to banking and financial stocks amid broader market weakness.Zee BusinessWhy are pharma stocks rising today? Tatva Chintan jumps 20%; Cipla, Torrent Pharma, Mankind gain; should you buy?Pharmaceutical stocks outperformed the broader Indian market on Monday, with the Nifty Pharma index rising 1.65% while the BSE Sensex fell 671 points. Tatva Chintan led the rally with a 20% jump to a new 52-week high of Rs 1,714.10 following its June-quarter financial results, while Torrent Pharma, Mankind Pharma, and Cipla each gained over 3%. The pharma sector's strength was driven by company-specific developments including quarterly earnings and brokerage recommendations, contrasting with weakness in banking and financial stocks amid concerns over Middle East conflict and higher crude oil prices.